ES2621663T3 - Método de conservación de muestras y sustrato de conservación de muestras - Google Patents
Método de conservación de muestras y sustrato de conservación de muestras Download PDFInfo
- Publication number
- ES2621663T3 ES2621663T3 ES12846138.1T ES12846138T ES2621663T3 ES 2621663 T3 ES2621663 T3 ES 2621663T3 ES 12846138 T ES12846138 T ES 12846138T ES 2621663 T3 ES2621663 T3 ES 2621663T3
- Authority
- ES
- Spain
- Prior art keywords
- paper
- weight
- ficoll
- fibers
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 38
- 238000004321 preservation Methods 0.000 title claims description 16
- 239000000758 substrate Substances 0.000 title description 15
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 52
- 239000000835 fiber Substances 0.000 claims abstract description 31
- 239000012472 biological sample Substances 0.000 claims abstract description 23
- 239000003365 glass fiber Substances 0.000 claims abstract description 9
- 229920003043 Cellulose fiber Polymers 0.000 claims abstract description 6
- 229920001917 Ficoll Polymers 0.000 claims description 87
- 238000011084 recovery Methods 0.000 claims description 53
- 102000004169 proteins and genes Human genes 0.000 claims description 51
- 108090000623 proteins and genes Proteins 0.000 claims description 51
- 239000000523 sample Substances 0.000 claims description 43
- 210000004369 blood Anatomy 0.000 claims description 37
- 239000008280 blood Substances 0.000 claims description 37
- 229920000642 polymer Polymers 0.000 claims description 34
- 238000004458 analytical method Methods 0.000 claims description 32
- 238000003860 storage Methods 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 238000001035 drying Methods 0.000 claims description 22
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 3
- 150000007942 carboxylates Chemical group 0.000 claims description 2
- 125000003700 epoxy group Chemical group 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 33
- 102100032752 C-reactive protein Human genes 0.000 description 33
- 239000000243 solution Substances 0.000 description 31
- 229920002307 Dextran Polymers 0.000 description 27
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 24
- 229960002086 dextran Drugs 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 230000008878 coupling Effects 0.000 description 15
- 238000010168 coupling process Methods 0.000 description 15
- 238000005859 coupling reaction Methods 0.000 description 15
- 230000008901 benefit Effects 0.000 description 14
- 238000002965 ELISA Methods 0.000 description 13
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 11
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 10
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 10
- 102000016267 Leptin Human genes 0.000 description 10
- 108010092277 Leptin Proteins 0.000 description 10
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical compound [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 10
- 229940039781 leptin Drugs 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 7
- 229940119743 dextran 70 Drugs 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 238000005470 impregnation Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 238000008157 ELISA kit Methods 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 150000001720 carbohydrates Chemical group 0.000 description 6
- 229940000986 dextran 110 Drugs 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 238000004949 mass spectrometry Methods 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 238000002791 soaking Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000002274 desiccant Substances 0.000 description 4
- -1 e.g. eg Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000012491 analyte Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- 238000011546 CRP measurement Methods 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 101000942118 Homo sapiens C-reactive protein Proteins 0.000 description 2
- 101000922020 Homo sapiens Cysteine and glycine-rich protein 1 Proteins 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 102000051143 human CRP Human genes 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 150000002924 oxiranes Chemical class 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 230000001012 protector Effects 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000000518 rheometry Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 101001063991 Homo sapiens Leptin Proteins 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000208465 Proteaceae Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000005937 allylation reaction Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000002344 aminooxy group Chemical group [H]N([H])O[*] 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 102000049953 human LEP Human genes 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000003328 mesylation reaction Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- BWYYYTVSBPRQCN-UHFFFAOYSA-M sodium;ethenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C=C BWYYYTVSBPRQCN-UHFFFAOYSA-M 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000007070 tosylation reaction Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H13/00—Pulp or paper, comprising synthetic cellulose or non-cellulose fibres or web-forming material
- D21H13/36—Inorganic fibres or flakes
- D21H13/38—Inorganic fibres or flakes siliceous
- D21H13/40—Inorganic fibres or flakes siliceous vitreous, e.g. mineral wool, glass fibres
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H17/00—Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
- D21H17/20—Macromolecular organic compounds
- D21H17/21—Macromolecular organic compounds of natural origin; Derivatives thereof
- D21H17/22—Proteins
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H17/00—Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
- D21H17/20—Macromolecular organic compounds
- D21H17/21—Macromolecular organic compounds of natural origin; Derivatives thereof
- D21H17/24—Polysaccharides
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H17/00—Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
- D21H17/20—Macromolecular organic compounds
- D21H17/33—Synthetic macromolecular compounds
- D21H17/46—Synthetic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D21H17/52—Epoxy resins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/2813—Producing thin layers of samples on a substrate, e.g. smearing, spinning-on
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/12—Specific details about materials
- B01L2300/126—Paper
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Inorganic Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Paper (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201118731 | 2011-10-31 | ||
| GB1118731.7A GB2496122A (en) | 2011-10-31 | 2011-10-31 | Biological sample preservation on paper |
| PCT/SE2012/051168 WO2013066249A1 (en) | 2011-10-31 | 2012-10-29 | Sample preservation method and sample preservation substrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2621663T3 true ES2621663T3 (es) | 2017-07-04 |
Family
ID=45375549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12846138.1T Active ES2621663T3 (es) | 2011-10-31 | 2012-10-29 | Método de conservación de muestras y sustrato de conservación de muestras |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10371608B2 (enExample) |
| EP (1) | EP2773956B1 (enExample) |
| JP (1) | JP6143765B2 (enExample) |
| ES (1) | ES2621663T3 (enExample) |
| GB (1) | GB2496122A (enExample) |
| WO (1) | WO2013066249A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9040679B2 (en) | 2012-04-30 | 2015-05-26 | General Electric Company | Methods and compositions for extraction and storage of nucleic acids |
| US9040675B2 (en) | 2012-04-30 | 2015-05-26 | General Electric Company | Formulations for nucleic acid stabilization on solid substrates |
| US9480966B2 (en) | 2012-04-30 | 2016-11-01 | General Electric Company | Substrates and methods for collection, stabilization and elution of biomolecules |
| US9044738B2 (en) | 2012-04-30 | 2015-06-02 | General Electric Company | Methods and compositions for extraction and storage of nucleic acids |
| US20150132746A1 (en) * | 2012-05-31 | 2015-05-14 | University Of Oslo | Sampling medium |
| GB2538955A (en) * | 2015-05-29 | 2016-12-07 | Ge Healthcare Uk Ltd | Improvements in and relating to extracting biological analytes |
| HK1258397A1 (zh) | 2015-09-09 | 2019-11-08 | Drawbridge Health, Inc. | 用於样品收集、稳定化和保存的系统、方法和装置 |
| SG10201911879UA (en) | 2017-01-10 | 2020-01-30 | Drawbridge Health Inc | Devices, systems, and methods for sample collection |
| JP6904561B2 (ja) * | 2017-02-22 | 2021-07-21 | 独立行政法人国立病院機構 | 乾燥血液試料保存基材 |
| WO2018155410A1 (ja) * | 2017-02-22 | 2018-08-30 | 公益財団法人ヒューマンサイエンス振興財団 | 乾燥血液試料保存基材 |
| WO2020032270A1 (ja) * | 2018-08-09 | 2020-02-13 | 公益財団法人ヒューマンサイエンス振興財団 | 乾燥血液試料保存基材 |
| CA3196351A1 (en) * | 2020-10-20 | 2022-04-28 | Definitek, Inc. | Quantification of previously undetectable quantities |
| EP4677062A2 (en) * | 2023-03-08 | 2026-01-14 | IMYOO Inc. | Compositions and methods for whole blood preservation |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3070486A (en) * | 1958-12-15 | 1962-12-25 | Ohio Commw Eng Co | Cigarette paper products comprising water insoluble dextran |
| US3300474A (en) | 1964-02-12 | 1967-01-24 | Pharmacia Ab | Sucrose ether copolymerizates |
| US3645692A (en) * | 1968-07-15 | 1972-02-29 | Boehringer Mannheim Gmbh | Process for the preparation, preservation and transportation of blood and serum samples for use in clinical analyses |
| AU2919171A (en) * | 1970-05-27 | 1972-11-30 | Pharmacia Ab | A method for carrying out tests, a reagent andan additive for carrying out the method |
| CA1318588C (en) * | 1988-01-19 | 1993-06-01 | Henry Jeong | Method and device for separating plasma from red cells |
| JP2728757B2 (ja) * | 1988-02-11 | 1998-03-18 | キューノ，インコーポレーテッド | 変性多糖支持体の親和性マトリックス |
| JPH01291164A (ja) * | 1988-05-19 | 1989-11-22 | Fujirebio Inc | 標準瀘紙用組成物 |
| US5252489A (en) * | 1989-01-17 | 1993-10-12 | Macri James N | Down syndrome screening method utilizing dried blood samples |
| CA2127605A1 (en) * | 1993-12-23 | 1995-06-24 | Peter J. Degen | Affinity separation method |
| US5725774A (en) * | 1995-04-07 | 1998-03-10 | Lxn Corp. | Whole blood separation method and devices using the same |
| US6309887B1 (en) * | 1998-01-27 | 2001-10-30 | Flexsite Diagnostics, Inc. | Filter paper treatment for improved diagnostic assays |
| DE10036907B4 (de) * | 2000-07-28 | 2012-03-22 | Xantec Bioanalytics Gmbh | Verfahren zur Herstellung einer Beschichtung auf einem mit Gold bedampften Glassubstrat, Beschichtung hergestellt nach diesem Verfahren und deren Verwendung |
| WO2003020924A2 (en) * | 2001-09-05 | 2003-03-13 | Whatman Plc | Stable storage of proteins |
| JP2009092651A (ja) * | 2007-09-20 | 2009-04-30 | Fujifilm Corp | 担体およびその製造方法 |
| WO2009090174A1 (en) * | 2008-01-17 | 2009-07-23 | Whatman Inc | Composite membrane blends comprising ionic branch polymers and methods of use |
| US20100209957A1 (en) * | 2008-06-20 | 2010-08-19 | Genvault Corporation | Biosample storage devices and methods of use thereof |
| BRPI0923565A2 (pt) | 2008-12-23 | 2016-01-26 | 3M Innovative Properties Co | artigo não tecido funcionalizado |
-
2011
- 2011-10-31 GB GB1118731.7A patent/GB2496122A/en not_active Withdrawn
-
2012
- 2012-10-29 JP JP2014538753A patent/JP6143765B2/ja active Active
- 2012-10-29 EP EP12846138.1A patent/EP2773956B1/en active Active
- 2012-10-29 WO PCT/SE2012/051168 patent/WO2013066249A1/en not_active Ceased
- 2012-10-29 ES ES12846138.1T patent/ES2621663T3/es active Active
- 2012-10-29 US US14/355,027 patent/US10371608B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6143765B2 (ja) | 2017-06-07 |
| US20140302521A1 (en) | 2014-10-09 |
| GB201118731D0 (en) | 2011-12-14 |
| EP2773956A4 (en) | 2015-06-17 |
| EP2773956A1 (en) | 2014-09-10 |
| US10371608B2 (en) | 2019-08-06 |
| WO2013066249A1 (en) | 2013-05-10 |
| EP2773956B1 (en) | 2017-03-15 |
| GB2496122A (en) | 2013-05-08 |
| JP2014535011A (ja) | 2014-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6143765B2 (ja) | 試料保存方法及び試料保存基材 | |
| ES2954376T3 (es) | Método para diagnosticar de manera precisa una enfermedad mediante biomarcadores de interés en una biopsia líquida | |
| CN101605591B (zh) | 交联的纤维素膜 | |
| KR20180016734A (ko) | 면역 측정법, 면역 크로마토그래프 키트 | |
| Libertino et al. | Biosensor integration on Si-based devices: Feasibility studies and examples | |
| CN107709251A (zh) | 用于分析样品制备的组合物和方法 | |
| US3925017A (en) | Preparation of dry, porous gel particles having high water regain for liquid sampling | |
| ES2909503T3 (es) | Micropartículas de celulosa colorantes hidrófilas | |
| EP3136096B1 (en) | Combination for target marker detection | |
| ES2367615B1 (es) | Sistema y procedimiento multianalítico basado en mediciones impedimétricas. | |
| Chaipet et al. | Sustainable hybrid sorbent based on a thin film gelatin coating over cellulose paper for the determination of steroid hormones in urine and environmental water samples | |
| Efstathiou et al. | Development of colorimetric PEG-based hydrogel sensors for urea detection | |
| US11971415B2 (en) | Microalbumin creatinine assay detection flag and methods of production and use related thereto | |
| Podorozhko et al. | A study of cryostructuring of a polymer system. 39. Poly (vinyl alcohol) composite cryogels filled with chitosan microparticles | |
| Duncan et al. | Preparation and characterization of a poly (2-hydroxyethyl methacrylate) biomedical hydrogel | |
| ES2818198T3 (es) | Sistema y dispositivos de ensayo de actividad enzimática | |
| ES2781322T3 (es) | Determinación de sarcosina utilizando sarcosina oxidasa y peroxidasa de rábano picante unidas a nanopartículas de Fe2O3/AU mediante quitosano | |
| JP7857667B2 (ja) | 血漿又は血清を分離し保管するための媒体、それを製造する方法、デバイス、キット、及び糖化タンパク質の測定方法 | |
| Gaur et al. | 4, 4′-Dimethyloxytrityl chloride: a reagent for the spectrophotometric determination of polymer-supported amino groups | |
| CN110938147B (zh) | 一种玻璃毛细管表面抗体固定方法 | |
| US9389224B2 (en) | Coated beads | |
| Nikolić et al. | Influence of periodate oxidation on sorption properties of viscose yarn | |
| EP3942059A1 (en) | Dried reagent polysaccharide surface area stabilization | |
| Shaimi et al. | Investigating membrane material and morphology for development of lateral flow biosensor | |
| JPH11201973A (ja) | エンドトキシン特異的ライセートの製造方法 |